Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41681684 | 4168168 | 4 | F | 20031211 | 20160823 | 20040714 | 20160823 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-12633269 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 2.89000 | KG | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41681684 | 4168168 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | 50 MG, QD | U | 21436 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 41681684 | 4168168 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 41681684 | 4168168 | CA |
| 41681684 | 4168168 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 41681684 | 4168168 | Breech presentation | |
| 41681684 | 4168168 | Foetal exposure during pregnancy | |
| 41681684 | 4168168 | Neonatal disorder | |
| 41681684 | 4168168 | Synostosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |